Zevra Therapeutics, Inc. (ZVRA) Earnings Per Share (EPS)
Zevra Therapeutics, Inc. (ZVRA) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | -$0.68 |
| 2017-12-31 | -$0.72 |
| 2018-12-31 | N/A |
| 2019-12-31 | -$0.83 |
| 2020-12-31 | -$3.21 |
| 2021-12-31 | -$2.11 |
| 2022-12-31 | -$1.20 |
| 2023-12-31 | -$1.30 |
| 2024-12-31 | -$2.28 |
| 2025-12-31 | $1.40 |
How ZVRA compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | $1.80 |
| USPH | U.S. Physical Therapy Inc. | $1.42 |
| BCRX | BioCryst Pharmaceuticals Inc. | $1.21 |
| ADMA | ADMA Biologics Inc | $0.60 |
| VCEL | Vericel Corporation | $0.32 |
These are five companies in the same sector as ZVRA with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Zevra Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("ZVRA")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ZVRA | $11.88 | +1.24% | 0.58M |
| 3 | ||||
| 4 | ||||
| 5 |